UroGen Pharma URGN
NASDAQ URGN
$35.30 -0.18 (-0.51%)
As of: Oct 22, 2026 · 9:48 AM EDT

UroGen Pharma (URGN) Other financing activities (2017 - 2022)

Updated

UroGen Pharma (URGN) recorded Other financing activities of $215,000 in FY2018, up 411.9% from $42,000 in FY2017.

Analysis

UroGen Pharma (URGN) Other financing activities (2017 - 2022) Analysis & Trends

  • Per Business Quant data, URGN's Other financing activities was $42,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 UroGen Pharma 1.78 Bn 1.28 Bn 65.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -16,000.00
Jun 30, 2022 -55,000.00
Mar 31, 2022 -89,000.00
Dec 31, 2021 -17,000.00
Sep 30, 2021 -116,000.00
Jun 30, 2021 -11,000.00
Dec 31, 2020 -11,000.00
Mar 31, 2020 -203,000.00
Mar 31, 2017 -112,000.00
API Access

UroGen Pharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=URGN&period=max&api_key=YOUR_API_KEY